Table 2.

Experiment 2: mean exploration times ± SEM during the sample or test phase after bilateral infusions of vehicle or AP5 into the mPFC or PRH or unilateral infusions into both the PRH and mPFC in the object-in-place task (5 min delay)

DelayDrug/sidemPFCPRHUnilateral mPFC and PRH
Expl. in sample phase (s)Expl. in test phase (s)Expl. in sample phase (s)Expl. in test phase (s)Expl. in sample phase (s)Expl. in test phase (s)
5 minVeh53.7 ± 4.420.3 ± 2.061.3 ± 3.620.5 ± 2.2
AP556.1 ± 3.617.5 ± 2.358.8 ± 4.320.9 ± 2.4
Ipsi41.9 ± 2.412.6 ± 1.8
Contra36.0 ± 2.312.2 ± 1.4
1 hVeh71.5 ± 6.825.5 ± 2.648.5 ± 3.516.2 ± 1.9
AP568.3 ± 3.422.9 ± 3.850.0 ± 2.6517.4 ± 1.9
Ipsi54.9 ± 4.417.6 ± 2.1
Contra49.9 ± 2.518.0 ± 1.7
  • Expl., Exploration; Veh, vehicle.